Radiofrequency Ablation Fixes Mesothelioma Recurrence in Case Study

Radiofrequency ablation (RFA) has been used successfully in Japan to treat post-surgery recurrence of malignant pleural mesothelioma, according to a case study published recently by the Society of Thoracic Surgeons. Although RFA has been utilized for several years to treat various thoracic lesions, the study authors believe this is the first time it worked effectively with mesothelioma cancer cells. “It shows promising efficacy,” the authors wrote. “Radiofrequency should be considered an option for treating recurrence of MPM [malignant pleural mesothelioma].” RFA is a minimally invasive medical procedure that utilizes the electrical energy of radiofrequency to generate enough heat to kill tumor cells without damaging surrounding tissue. It has received considerable attention in recent years for its use on tiny, inoperable lung lesions, although many oncologists have been reluctant to recommend it. There is considerable debate over its efficacy and safety. Clinical Trials Testing Effectiveness of RFA There are close to 100 clinical trials in the recruiting stage today that involve RFA in various combination treatments for a variety of malignancies. The treatment is being monitored closely because recurrence with pleural mesothelioma is almost inevitable after first-line treatment, creating a demand for more effective adjuvant therapy. Unfortunately, there currently is no FDA-approved second-line treatment when the recurrence happens with mesothelioma. “The best ther...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news